rs143873934
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_031471.6(FERMT3):c.607C>T(p.Pro203Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,610,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_031471.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000802 AC: 122AN: 152064Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000167 AC: 40AN: 239746Hom.: 0 AF XY: 0.000107 AC XY: 14AN XY: 131008
GnomAD4 exome AF: 0.0000734 AC: 107AN: 1458218Hom.: 0 Cov.: 37 AF XY: 0.0000744 AC XY: 54AN XY: 725366
GnomAD4 genome AF: 0.000802 AC: 122AN: 152182Hom.: 0 Cov.: 31 AF XY: 0.000820 AC XY: 61AN XY: 74386
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.607C>T (p.P203S) alteration is located in exon 5 (coding exon 4) of the FERMT3 gene. This alteration results from a C to T substitution at nucleotide position 607, causing the proline (P) at amino acid position 203 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Leukocyte adhesion deficiency 3 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at